Binh Dinh Pharmaceutical and Medical Equipment JSC (HOSE: DBD)
Vietnam
· Delayed Price · Currency is VND 45,000
0.00 (0.00%)
At close: Oct 3, 2024
DBD Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 265,680 | 269,055 | 243,555 | 189,124 | 157,860 | 142,227 | Upgrade
|
| Depreciation & Amortization | 43,068 | 43,211 | 41,665 | 38,689 | 31,809 | 27,945 | Upgrade
|
| Other Amortization | 3,473 | 2,759 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -21,548 | -28,704 | -13,801 | -5,488 | -24,247 | -27,371 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | - | - | - | 14,548 | Upgrade
|
| Other Operating Activities | 12,523 | 16,952 | 21,843 | 20,760 | -6,903 | -21,522 | Upgrade
|
| Change in Accounts Receivable | 47,761 | 72,231 | -28,740 | -85,346 | 29,325 | -58,930 | Upgrade
|
| Change in Inventory | 17,315 | -48,018 | -196,262 | -39,176 | 98,059 | -43,238 | Upgrade
|
| Change in Accounts Payable | -35,066 | -28,608 | 97,633 | -5,683 | -71,593 | -20,185 | Upgrade
|
| Change in Other Net Operating Assets | -987.51 | -4,886 | -882.62 | 4,687 | -1,402 | -14,511 | Upgrade
|
| Operating Cash Flow | 332,219 | 293,991 | 165,012 | 117,568 | 212,908 | -1,036 | Upgrade
|
| Operating Cash Flow Growth | 141.36% | 78.16% | 40.35% | -44.78% | - | - | Upgrade
|
| Capital Expenditures | -174,344 | -133,694 | -82,828 | -54,636 | -59,734 | -149,628 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | 1 | 4,000 | - | Upgrade
|
| Investment in Securities | 9,889 | 18,060 | -82,189 | - | 13,000 | 108,760 | Upgrade
|
| Other Investing Activities | -1,334 | 397.54 | 7,326 | 5,268 | 9,273 | 21,615 | Upgrade
|
| Investing Cash Flow | -165,788 | -115,236 | -157,691 | -95,227 | -2,143 | -19,252 | Upgrade
|
| Long-Term Debt Issued | - | 216,778 | - | 50,916 | 241,184 | 507,755 | Upgrade
|
| Total Debt Issued | 71,420 | 216,778 | - | 50,916 | 241,184 | 507,755 | Upgrade
|
| Long-Term Debt Repaid | - | -213,511 | -21,029 | -37,162 | -400,882 | -363,329 | Upgrade
|
| Total Debt Repaid | -128,536 | -213,511 | -21,029 | -37,162 | -400,882 | -363,329 | Upgrade
|
| Net Debt Issued (Repaid) | -57,116 | 3,267 | -21,029 | 13,754 | -159,699 | 144,425 | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | -1,952 | - | Upgrade
|
| Common Dividends Paid | -72.05 | -149,698 | - | -75,553 | -78,548 | -78,531 | Upgrade
|
| Financing Cash Flow | -57,188 | -146,431 | -21,029 | -61,799 | -240,198 | 65,894 | Upgrade
|
| Foreign Exchange Rate Adjustments | -18.92 | -49.2 | - | - | - | -0.01 | Upgrade
|
| Net Cash Flow | 109,224 | 32,275 | -13,709 | -39,458 | -29,433 | 45,605 | Upgrade
|
| Free Cash Flow | 157,875 | 160,298 | 82,184 | 62,932 | 153,173 | -150,664 | Upgrade
|
| Free Cash Flow Growth | 325.87% | 95.05% | 30.59% | -58.91% | - | - | Upgrade
|
| Free Cash Flow Margin | 9.44% | 9.70% | 5.29% | 4.04% | 12.19% | -11.94% | Upgrade
|
| Free Cash Flow Per Share | 1687.53 | 1713.42 | 878.47 | 672.68 | 1636.12 | -1609.19 | Upgrade
|
| Cash Interest Paid | 5,070 | 7,166 | 1,916 | 869.42 | 5,914 | 9,955 | Upgrade
|
| Cash Income Tax Paid | 56,434 | 38,168 | 55,332 | 52,859 | 44,513 | 13,022 | Upgrade
|
| Levered Free Cash Flow | 45,429 | 105,962 | 20,718 | -48,957 | 148,357 | -95,725 | Upgrade
|
| Unlevered Free Cash Flow | 48,516 | 110,336 | 21,915 | -48,129 | 152,475 | -89,278 | Upgrade
|
| Change in Net Working Capital | 7,357 | -12,447 | 107,760 | 167,888 | -66,786 | 68,064 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.